One of the biggest potential impacts is to the supply chain, says John Ransom, managing director of healthcare research. “We source a lot of [active pharmaceutical ingredients] from India and China.”
Recorded February 25, 2020
Markets & Investing May 30, 2023 Nick Goetze discusses fixed income market conditions and offers insight...
Economy & Policy May 26, 2023 Chief Economist Eugenio J. Alemán discusses current economic...
Markets & Investing May 26, 2023 Review the latest Weekly Headings by CIO Larry Adam. Key...